A biotech renaissance is emerging in the East.

Fearless founders, regulatory agility, massive capital inflows.

This month & next, we're touring Asia with DeSci summits, a bio/acc rave & countless IRL meetings.

Here are some places we’ll be. RSVP links below. DM to meet.

Captain Science

The next leap has already started.

$DICK is live & liquid on Bio!

@D1ckGPT
is your AI-personalized men's health agent built to track & reverse your D-Age. Trained on clinician-curated research and live studies by
@D1ckDAO
researchers, the agent is engineered to reverse men's biological aging through science-backed health optimization.

CA: 0xE183b1A4DD59Ca732211678EcA1836EE35bCE582

Claim and swap DICK in the Bio App: https://app.bio.xyz/agents/d1ckgpt

→ Selling >50% of your Ignition allocation within the first 2 weeks results in your BioXP earning power being paused for 3 weeks.

→ A BIO/DICK liquidity pool is now live supporting trading in the token and generating a continuous stream of research funding for the D1ckGPT team to execute on their roadmap and finance experiments that feed the agent data & value.

→ Staking for $DICK will go live soon, allowing you to earn more BioXP for the next Ignition Sales.

See the project roadmap below and use the
@D1ckGPT
agent for men's health advice & research.

Last week in the Biosphere:

• VitaSTEM, the 1st
@Aubrai_
IP Token, shows how humans + AI Agents can co-drive R&D

• Men’s Health BioAgent
@D1ckGPT
launches w/ Thailand-based doctors

•
@Aubrai_
hits funding milestone

• BioXP revamp underway

Read the full weekly report ↓

Meet the team behind Curetopia.

Scientists who have spent decades advancing treatments for rare diseases.

Ethan Perlstein, Ph.D. (
@eperlste
)founded Perlara and Curetopia, pioneering patient-led biotech and translational research.

Kristin Kantautas, Ph.D. (
@wolfeofscience
) is a molecular geneticist leading drug repurposing programs for congenital metabolic disorders.

Mathuravani Thevandavakkam, Ph.D. is a synthetic biologist pushing yeast-model–based therapies for underserved communities.

Shiri Zakin, Ph.D. is a mitochondrial disease specialist with more than 20 years of experience driving patient-centered drug discovery.

It’s time for Bio to evolve from a curated launchpad into a permissionless factory for decentralized biotech.

Stake $BIO to join the upcoming S2 Ignition Sales.

$GALE Ignition Sale Closed

@NEURONGale
has exceeded its funding goal.

14.2X oversubscribed 🧠

$712K USDC committed by 1,900+ participants.

> TGE expected within the next hour. DEX trading via
@AerodromeFi
will be supported in the Bio App.

> GALE staking will go live around the time of the TGE.

> $BIO stakers who also stake GALE get up to 10X rewards from the New Token Multiplier 🔮

> Use BioXP earnings on the next Ignition Sales, starting next week.

> veBIO holders automatically receive a GALE airdrop once Ecosystem Airdrops are activated, enabling passive exposure to the network as it grows.

📺 Join us at 11:30am UTC TODAY for a livestream with the Neuron Gale team (RSVP link below)

Announcing DeSci Summit Abu Dhabi 2025

This year's summit explores the next era of AI + biology, neuroscience, genetic engineering, longevity & more.

December 10th at Cleveland Clinic Abu Dhabi.

Featuring:
•
@eboyden3
(Neuroscientist, MIT)
•
@james_maggie91
(Pro Athlete, Enhanced Games)
• Dr. Axel Bouchon (Co-founder & CEO, Matter Neuroscience)
•
@paulkhls
(Co-founder & CEO, Bio & Molecule)
•
@sebastian_gero
(Co-founder & Partner, LongGame Ventures)

+ many more!

Register in the link below👇

The HIP-3 DEX @tradexyz has surpassed $250,000,000,000 in total trading volume.

Priority Fees generated more fees over the past 24 hours than solana's chain revenue.